This page is an unofficial LFoD record and is not legal advice. Verify the document against the official source before relying on it.

SB224: relative to insurance coverage for pediatric autoimmune neuropsychiatric disorders.

Bill status: Signed by Governor

Bill details

Version history, amendments, and roll-call votes were not present in the imported local bill data.

Sponsors

Topics

Commerce and Consumer Affairs Health care Insurance

Official links

CHAPTER 277

SB 224-FN - FINAL VERSION

03/07/2019 0590s

8May2019... 1673h

2019 SESSION

19-1020

01/10

SENATE BILL 224-FN

AN ACT relative to insurance coverage for pediatric autoimmune neuropsychiatric disorders.


AMENDED ANALYSIS

This bill clarifies insurance coverage for treatment for pediatric autoimmune neuropsychiatric disorders.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Explanation: Matter added to current law appears in bold italics.

Matter removed from current law appears [in brackets and struckthrough.]

Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.

03/07/2019 0590s

8May2019... 1673h 19-1020

01/10

STATE OF NEW HAMPSHIRE

In the Year of Our Lord Two Thousand Nineteen

AN ACT relative to insurance coverage for pediatric autoimmune neuropsychiatric disorders.

Be it Enacted by the Senate and House of Representatives in General Court convened:

277:1 Coverage for Certain Biologically-Based Mental Illnesses. Amend RSA 417-E:1, II to read as follows:

II. Notwithstanding any other provision of law, each insurer that issues or renews any policy of [group] accident or health insurance and each nonprofit health service corporation under RSA 420-A and health maintenance organization under RSA 420-B providing benefits for disease or sickness in the state of New Hampshire shall provide benefits for treatment and diagnosis of certain biologically-based mental illnesses under the same terms and conditions and which are no less extensive than coverage provided for any other type of health care for physical illness.

277:2 Coverage for Certain Biologically-Based Mental Illnesses. Amend RSA 417-E:1, III(f) to read as follows:

(f) Obsessive-compulsive disorder, including pediatric autoimmune neuropsychiatric disorders, when treatment, including the use of intravenous immunoglobulin therapy, is ordered by a physician.

277:3 Coverage for Certain Biologically-Based Mental Illnesses. RSA 417-E:1, III(f) is repealed and reenacted to read as follows:

(f) Obsessive-compulsive disorder, including pediatric autoimmune neuropsychiatric disorders.

277:4 Effective Date.

I. Section 3 of this act shall take effect July 1, 2024.

II. The remainder of this act shall take effect 60 days after its passage.

Approved: July 19, 2019

Effective Date:

I. Section 3 shall take effect July 1, 2024.

II. Remainder shall take effect September 17, 2019.